Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Vacca

Showing results (1-10 of 347) with videos related to

Pageof 35
Sort By:
International Journal of Molecular Sciences|January 23, 2020
Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple MyelomaRoberto Ria, Angelo Vacca
Blood|May 2, 2009
MicroRNAs to know in Waldenstrom macroglobulinemiaAngelo Vacca, Franco Dammacco
Genes & Nutrition|October 14, 2008
The role of microenvironment in tumor angiogenesisDomenico Ribatti, Angelo Vacca
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 22, 2011
Angiogenesis and vasculogenesis in multiple myeloma: role of inflammatory cellsAngelo Vacca, Domenico Ribatti
Haematologica|April 10, 2002
Is thalidomide a true anti-angiogenic molecule in multiple myeloma?Domenico Ribatti, Angelo Vacca
International Archives of Allergy and Immunology|June 25, 2021
Deflazacort versus Prednisone in the Treatment of Essential Mixed Cryoglobulinemia A Between-Patient Controlled Clinical StudyAngelo Vacca, Franco Dammacco
International Journal of Molecular Sciences|July 14, 2018
New Insights in Anti-Angiogenesis in Multiple MyelomaDomenico Ribatti, Angelo Vacca
Cancer Treatment and Research|October 4, 2016
Role of Endothelial Cells and Fibroblasts in Multiple Myeloma Angiogenic SwitchDomenico Ribatti, Angelo Vacca
Current Cancer Drug Targets|December 27, 2005
Novel therapeutic approaches targeting vascular endothelial growth factor and its receptors in haematological malignanciesDomenico Ribatti, Angelo Vacca
Current Pharmaceutical Biotechnology|December 16, 2006
Novel agents for multiple myeloma treatmentDomenico Ribatti, Angelo Vacca
Pageof 35

Showing results (1-10 of 347) with videos related to

Sort By:
Pageof 35
International Journal of Molecular Sciences|January 23, 2020
Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple MyelomaRoberto Ria, Angelo Vacca
Blood|May 2, 2009
MicroRNAs to know in Waldenstrom macroglobulinemiaAngelo Vacca, Franco Dammacco
Genes & Nutrition|October 14, 2008
The role of microenvironment in tumor angiogenesisDomenico Ribatti, Angelo Vacca
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 22, 2011
Angiogenesis and vasculogenesis in multiple myeloma: role of inflammatory cellsAngelo Vacca, Domenico Ribatti
Haematologica|April 10, 2002
Is thalidomide a true anti-angiogenic molecule in multiple myeloma?Domenico Ribatti, Angelo Vacca
International Archives of Allergy and Immunology|June 25, 2021
Deflazacort versus Prednisone in the Treatment of Essential Mixed Cryoglobulinemia A Between-Patient Controlled Clinical StudyAngelo Vacca, Franco Dammacco
International Journal of Molecular Sciences|July 14, 2018
New Insights in Anti-Angiogenesis in Multiple MyelomaDomenico Ribatti, Angelo Vacca
Cancer Treatment and Research|October 4, 2016
Role of Endothelial Cells and Fibroblasts in Multiple Myeloma Angiogenic SwitchDomenico Ribatti, Angelo Vacca
Current Cancer Drug Targets|December 27, 2005
Novel therapeutic approaches targeting vascular endothelial growth factor and its receptors in haematological malignanciesDomenico Ribatti, Angelo Vacca
Current Pharmaceutical Biotechnology|December 16, 2006
Novel agents for multiple myeloma treatmentDomenico Ribatti, Angelo Vacca
Pageof 35